AffinityImmuno Inc. is a Canadian biotechnology company providing high quality R&D products and services to for the global community with emphasis on biological drugs and biosimilars. We specialize in antibodies and bioanalytical methodologies for cancer, autoimmune disorders, and COVID-19. We offer several off-the-shelf ELISA kits and legacy monoclonal antibodies. We leverage our combined experience of over 30 years working in immunology and analytical chemistry to offer high quality products and service to quickly meet new challenges.